Delivery Order SPE2DB24D2105-SPE2DB24FAPPX

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,536.04 firm fixed-price delivery order is for the supply of KERENDIA 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,146.75 firm fixed-price delivery order is for the supply of KERENDIA 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025 and was awarded on January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of the pharmaceutical product KERENDIA 20 MG TABLET 30S. The $1,663.36 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer for Amerisourcebergen's federal contracting activities. The contract has a completion date of September 6, 2024 and is not set aside for any specific business type. Amerisourcebergen is a large...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,575.16 firm fixed price delivery order is for the supply of KERENDIA 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of May 23, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award, valued at $35,954.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of the medication KERENDIA 20 MG TABLET 90S, with a performance period ending on May 12, 2025. The contract is a firm-fixed-price arrangement and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,396.99 firm fixed-price delivery order is for the supply of Kerendia 10 mg tablets. The contract has an ultimate completion date of October 18, 2024 and was awarded on October 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,831.66, is for the delivery of Kerendia 10 mg tablets. It is a firm-fixed price delivery order contract that runs through December 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,570.64 firm-fixed-price contract is for the supply of KERENDIA 10 MG TABLET 90S, a specialty medication. The award is not designated with a set-aside. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,438.02 firm fixed-price delivery order contract is for the supply of KERENDIA 20 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 31, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,435.81 firm fixed-price delivery order is for the supply of KERENDIA 10 MG TABLET 30S, a pharmaceutical product, with a completion date of March 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2DB24D2105
    Indefinite Delivery Contract
  • SPE2DB24D2105-SPE2DB24FAPPX
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the prescription medication KERENDIA 10 MG TABLET 30S to the Defense Logistics Agency (DLA). The award, valued at $2,205.52, is a firm fixed-price delivery order with a final completion date of July 10, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. Amerisourcebergen's expertise in pharmaceutical distribution allows it to efficiently manage the complex logistics of supplying critical medical products to government agencies.

Generated 10/8/24, 9:14 AM